Healthcare is shifting fast as both consumers and providers push for a more proactive, personalized approach. People are investing in prevention — Function Health's trend-tracking lab panels even made TIME's 2025 Most Influential list. Meanwhile, health systems prioritize data-driven care, with the EU and NHS making interoperable health data an immediate priority and pilot programs rolling out across Europe this summer. Yet 80% of health data remains unstructured and untapped, with lab results as the largest source. Over 70% of clinical decisions depend on lab results, Europe produces billions yearly, but they're still scattered across PDFs and incompatible systems—making it impossible to track health trends, spot patterns, or power AI-driven insights.
The impact is significant: too many conditions are still caught late. Across health systems, including Europe, up to 15% of diagnoses are delayed or incorrect, consuming 17.5% of healthcare spending. In the EU alone, that equals nearly €290 billion every year. One in three adults with chronic conditions like diabetes goes undiagnosed, and even life-threatening diseases such as prostate cancer are often diagnosed late. Patients feel the gap too: a recent global survey found that 94% view access to their health data as crucial.
"We need to shift the paradigm in healthcare towards empowering patients to take ownership of their health. Bringing health data together in one place with personalized content will be key to healthcare's future." said Oke Eleazu, NHS Trust Chair.
Berlin-based healthtech startup OpenHealth Technologies has raised a $3M seed round to solve this critical gap—modernizing lab data infrastructure. The funding will accelerate European expansion and further develop the company's AI-driven medical platform.
The round was backed by new investors GoHub Ventures, xdeck ventures, Edenbase, and Exceptional Ventures, alongside renewed support from existing backers YZR Capital, Octopus Ventures and Calm/Storm Ventures, bringing OpenHealth's total funding to $4.3 million.
OpenHealth provides a lab data API that converts raw results from any source into harmonized, AI-ready data, and white-label solutions that visualize those results. Health and wellness companies embed it to add longitudinal insights to their products. Clinics and labs use it to share patient-friendly reports and deliver personalized care. OpenHealth is building toward creating the world's largest usable biomarker database, with longitudinal data designed to positively impact over 100 million lives.
Founded by a European team with clinical, technical, and health system expertise, OpenHealth is trusted by clients globally, including Latin America's largest diagnostics and hospital groups, market-leading fitness and wellness players like Smart Fit—the region's largest gym chain—European healthtech leaders such as Aware, and a growing network of longevity providers across Europe and the Americas.
“Our mission is clear: we want to empower people and organizations to use health data better. Most lab results today are fragmented, unstructured, and underutilized. We’re changing that by building the rails for a smarter, interoperable health ecosystem,” said Gerrit Glass, CEO and Founder of OpenHealth. “With this new round, we’re excited to accelerate our growth alongside new investors with deep B2B SaaS and AI expertise.”
OpenHealth will use the funding to accelerate its European expansion, bringing its platform to more laboratories, prevention and longevity clinics, supplement brands, pharmaceutical companies, and insurers. The investment will also support the development of AI-driven technology for personalised prevention and care.
“We’re proud to support OpenHealth’s journey,” said Pablo Perea, Partner at GoHub Ventures. “Their solution addresses a critical pain point in healthcare infrastructure. With the global push toward interoperability and patient-centred data, their timing and technology are spot on.”